Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.
Pietro Emiliano DonedduDario CocitoRaffaella FazioLuana BenedettiErdita PeciGiuseppe LiberatoreYuri Matteo FalzoneFrancesco GermanoFrancesca GalliaClaudia GiannottaCinta LleixàElisa BianchiEduardo Nobile-OrazioPublished in: Journal of neurology, neurosurgery, and psychiatry (2024)
NCT05877040.